Sunday, August 17, 2008
Genetech DNA Acquistion
Was Roche’s $89 per share offer for Genentech a true “fair and generous” offer, or just the first move in a long chess match? Genentech’s independent directors seem to believe the latter.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment